Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4094780
Max Phase: Preclinical
Molecular Formula: C39H51N15O6
Molecular Weight: 825.94
Molecule Type: Small molecule
Associated Items:
ID: ALA4094780
Max Phase: Preclinical
Molecular Formula: C39H51N15O6
Molecular Weight: 825.94
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)NN(Cc1c[nH]nn1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O
Standard InChI: InChI=1S/C39H51N15O6/c1-23(47-37(58)33(16-25-18-44-30-12-6-5-11-28(25)30)49-36(57)29(41)17-26-19-43-22-45-26)35(56)52-54(21-27-20-46-53-51-27)39(60)50-32(15-24-9-3-2-4-10-24)38(59)48-31(34(42)55)13-7-8-14-40/h2-6,9-12,18-20,22-23,29,31-33,44H,7-8,13-17,21,40-41H2,1H3,(H2,42,55)(H,43,45)(H,47,58)(H,48,59)(H,49,57)(H,50,60)(H,52,56)(H,46,51,53)/t23-,29-,31-,32+,33+/m0/s1
Standard InChI Key: UUTYKMNKIXJGEL-FEWVAFNBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 825.94 | Molecular Weight (Monoisotopic): 825.4147 | AlogP: -0.94 | #Rotatable Bonds: 21 |
Polar Surface Area: 329.91 | Molecular Species: BASE | HBA: 11 | HBD: 11 |
#RO5 Violations: 3 | HBA (Lipinski): 21 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 8.76 | CX Basic pKa: 9.93 | CX LogP: -3.54 | CX LogD: -5.05 |
Aromatic Rings: 5 | Heavy Atoms: 60 | QED Weighted: 0.03 | Np Likeness Score: -0.20 |
1. Chignen Possi K, Mulumba M, Omri S, Garcia-Ramos Y, Tahiri H, Chemtob S, Ong H, Lubell WD.. (2017) Influences of Histidine-1 and Azaphenylalanine-4 on the Affinity, Anti-inflammatory, and Antiangiogenic Activities of Azapeptide Cluster of Differentiation 36 Receptor Modulators., 60 (22): [PMID:29028172] [10.1021/acs.jmedchem.7b01209] |
Source(1):